4(α-L-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that defends cerebral tissue and prevents severe damage induced by focal ischemia/reperfusion

Journal of Biological Regulators and Homeostatic Agents

Volumn 29, Issue 2, 2015, Pages 343-356

  Galuppo, M ^a   Giacoppo, S ^a   Iori, R ^b   De Nicola, G R ^b   Milardi, D ^a   Bramanti, P ^a   Mazzon, E ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b Research Centre for Industrial Cultivation (CIN)   (Italy)

Author keywords

Cerebral ischemia reperfusion; Glucosinolate; Isothiocyanate; Moringa oleifera; Stroke

Indexed keywords

4-((ALPHA-L-RHAMNOSYLOXY)BENZYL)ISOTHIOCYANATE; GELATINASE B; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOTHIOCYANIC ACID DERIVATIVE; NERVE PROTEIN; NEUROPROTECTIVE AGENT; NF-KAPPAB INHIBITOR ALPHA; NOS2 PROTEIN, RAT; PADGEM PROTEIN; PLANT MEDICINAL PRODUCT; RELA PROTEIN, RAT; RHAMNOSE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BRAIN EDEMA; BRAIN ISCHEMIA; CAROTID ARTERY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GAIT DISORDERS, NEUROLOGIC; LIGATION; MALE; MORINGA OLEIFERA; NERVE CELL PLASTICITY; PATHOLOGY; PHYTOTHERAPY; PLANT SEED; PRECLINICAL STUDY; RANDOMIZATION; RAT; REPERFUSION INJURY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BRAIN EDEMA; BRAIN ISCHEMIA; CAROTID ARTERIES; CONSTRICTION; DRUG EVALUATION, PRECLINICAL; GAIT DISORDERS, NEUROLOGIC; I-KAPPA B PROTEINS; ISOTHIOCYANATES; MALE; MATRIX METALLOPROTEINASE 9; MOLECULAR STRUCTURE; MORINGA OLEIFERA; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; P-SELECTIN; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RHAMNOSE; SEEDS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84988372343     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol 2004; 3:391-93.
2. Baldwin KA, McCoy SL. Making a case for acute ischemic stroke. J Pharm Pract 2010; 23:387-97.
3. http://www.strokecenter.org/patients/about-stroke/stroke-statistics/. Stroke Stat.
4. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 1998; 18:758-67.
5. Yang QD, Niu Q, Zhou YH, et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis 2004; 17:303-13.
6. He J, Klag MJ, Wu Z, Whelton PK. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26:2228-32.
7. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet 2010; 376:112-123.
8. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007; 6:149-61.
9. Ou W, Liu X, Shen Y, et al. Association of CVD candidate gene polymorphisms with ischemic strokeand cerebral hemorrhage in Chinese individuals. PLoS One 2014; 9:e105516.
10. Breschi GL, Librizzi L, Pastori C, Zucca I, Mastropietro A, Cattalini A, de Curtis M. Functional and structural correlates of magnetic resonance patterns in a new in vitro model of cerebral ischemia by transient occlusion of the medial cerebral artery. Neurobiol Dis 2010; 39:181-91.
11. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014; 7:CD000213.
12. Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001; 56:5-51.
13. Brunelli D, Tavecchio M, Falcioni C, et al. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem Pharmacol 2010; 79:1141-48.
14. Galuppo M, Giacoppo S, De Nicola GR, et al. Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis. Fitoterapia 2014; 95:160-74.
15. McAuley MA. Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev 1995; 7:153-80.
16. Giacoppo S, Galuppo M, De Nicola G, et al. 4(alphal-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury. Bioorg Med Chem 2015; 23:80-88.
17. Feng J, Yan Z, Ferreira A, et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci U S A 2000; 97:9287-9292.
18. Nimchinsky EA, Sabatini BL, Svoboda K. Structure and function of dendritic spines. Annu Rev Physiol 2002; 64:313-53.
19. Tu Q, Cao H, Zhong W, Ding B, Tang X. Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects. Neural Regen Res 2014; 9:268-75.
20. Liu X, Mei Z, Qian J, Zeng Y, Wang M. Puerarin partly counteracts the inflammatory response after cerebral ischemia/reperfusion via activating the cholinergic anti-inflammatory pathway. Neural Regen Res 2013; 8:3203-15.
21. Yilmaz G, Granger DN. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 2010; 12:193-204.
22. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003; 24:2166-79.
23. Wang J, Jin H, Hua Y, Keep RF, Xi G. Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia. Stroke 2012; 43:2476-82.
24. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007; 6:258-68.
25. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996; 27:1373-80.